Key result
Apolipoprotein gene polymorphisms are linked to up to ~7-fold greater intra-individual lipid variability.
Cohort (n=1,581)
Answers are grounded in this paper and cite their sources.
We studied the influence of selected genetic markers on the intra‐individual long‐term variability in serum lipid levels. The study cohort consisted of a sub‐sample from a large follow‐up study of atherosclerosis precursors in children and young adults. A total of 320 subjects had determinations of apo B XbaI RFLP genotypes, 305 subjects had apo AI/CIII SstI RFLP genotype determinations and 1581 subjects had their apo E phenotypes determined. Complete data on serum lipids were available at 3‐year intervals over a 6‐year follow‐up period. The subjects were healthy and aged 3–18 years at baseline. Intra‐individual variability was assessed with a nested analysis of variance procedure. Each of the genetic markers studied here significantly affected intra‐individual variability of serum lipid levels. No clear sex influence was observed, although the differences in variability tended to be more significant in males. Apo B XbaI genotypes significantly influenced intra‐individual variability of total and LDL‐cholesterol levels in both sexes. A marked effect of the XbaI geno‐type was also found on triglyceride variability. In males the standardized intra‐individual triglyceride variances were 0.71 and 0.34 in genotypes X1X1 and X2X2, respectively (p < 0.001), with a clear gene dosage effect. The apo AI/CIII genotype had an influence only on the variability of total cholesterol and LDL‐cholesterol levels and only in males. The apo E phenotypes were associated with intra‐individual variability in total and LDL‐cholesterol levels but again, only in males. The lowest variability was observed in the phenotype E4/3 where high mean values were also observed. We also examined the effect of combined genetic markers. Up to 7 times greater variability was found in the combination E3/2 + S1S1 compared to combination E4/3 + S1S2 (p < 0.001). In addition, mean levels of, e.g., LDL‐cholesterol were 70% greater in the combination of E4/3 +S1S2 compared to E3/2 + S1S1. This implies that subjects with both these genetic markers have high LDL‐cholesterol values that also tend to remain constantly elevated. In conclusion, it is evident that many of the presently known DNA polymorphisms of the coronary heart disease candidate gene loci also influence intraindividual variability of serum lipid or lipoprotein levels. These findings can be used to further refine our ability to predict the risk of a cardiovascular event.
No takes yet. Share an insight, caveat, or question.
Porkka et al. (1994) conducted a cohort in Intra-individual variability in serum lipid levels / Atherosclerosis precursors (n=1,581). DNA polymorphisms at apo B (XbaI), apo AI/CIII (SstI), and apo E loci vs. Alternate genotypes/phenotypes (e.g., X1X1 vs X2X2; E3/2 + S1S1 vs E4/3 + S1S2) was evaluated on Intra-individual long-term variability in serum lipid levels (total cholesterol, LDL-cholesterol, and triglycerides) (p=<0.001). Apo B, AI/CIII, and E polymorphisms affected intra-individual lipid variability, with up to 7-fold greater variability in E3/2+S1S1 vs E4/3+S1S2.
Synapse has enriched 10 related papers. Consider them for comparative context: